Uni-Bio Science Group Limited (0690.HK)
HKD 0.08
(2.67%)
HKD 0.08
(2.67%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 30.61 Million HKD | 309.8% |
| 2022 | 7.47 Million HKD | 658.38% |
| 2021 | 985 Thousand HKD | -53.25% |
| 2020 | 2.1 Million HKD | 0.0% |
| 2019 | - HKD | 0.0% |
| 2018 | - HKD | 0.0% |
| 2017 | - HKD | 0.0% |
| 2016 | - HKD | 0.0% |
| 2015 | - HKD | 0.0% |
| 2014 | - HKD | 0.0% |
| 2013 | - HKD | -100.0% |
| 2012 | 97.8 Million HKD | 91.27% |
| 2011 | 51.13 Million HKD | 3209.58% |
| 2010 | 1.54 Million HKD | 0.0% |
| 2009 | - HKD | -100.0% |
| 2008 | 15.34 Million HKD | 0.0% |
| 2007 | - HKD | -100.0% |
| 2006 | 89.02 Million HKD | 135.24% |
| 2005 | 37.84 Million HKD | 0.0% |
| 2004 | - HKD | 0.0% |
| 2003 | - HKD | -100.0% |
| 2002 | 18.51 Million HKD | 95.98% |
| 2001 | 9.44 Million HKD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 49.6 Million HKD | 0.0% |
| 2024 Q1 | 49.6 Million HKD | 62.04% |
| 2023 Q1 | 6.11 Million HKD | -18.21% |
| 2023 Q3 | 37.6 Million HKD | 515.42% |
| 2023 Q2 | 6.11 Million HKD | 0.0% |
| 2023 Q4 | 30.61 Million HKD | -18.59% |
| 2023 FY | 30.61 Million HKD | 309.8% |
| 2022 Q1 | 5.24 Million HKD | 431.98% |
| 2022 Q3 | 7.47 Million HKD | 42.56% |
| 2022 FY | 7.47 Million HKD | 658.38% |
| 2022 Q4 | 7.47 Million HKD | 0.0% |
| 2022 Q2 | 5.24 Million HKD | 0.0% |
| 2021 Q4 | 985 Thousand HKD | 0.0% |
| 2021 FY | 985 Thousand HKD | -53.25% |
| 2021 Q1 | 3.28 Million HKD | 55.86% |
| 2021 Q2 | 3.28 Million HKD | 0.0% |
| 2021 Q3 | 985 Thousand HKD | -70.01% |
| 2020 Q1 | - HKD | 0.0% |
| 2020 FY | 2.1 Million HKD | 0.0% |
| 2020 Q2 | - HKD | 0.0% |
| 2020 Q3 | 2.1 Million HKD | 0.0% |
| 2020 Q4 | 2.1 Million HKD | 0.0% |
| 2019 FY | - HKD | 0.0% |
| 2019 Q1 | 83 Thousand HKD | 0.0% |
| 2019 Q2 | 83 Thousand HKD | 0.0% |
| 2019 Q3 | - HKD | -100.0% |
| 2019 Q4 | - HKD | 0.0% |
| 2018 Q2 | - HKD | 0.0% |
| 2018 FY | - HKD | 0.0% |
| 2018 Q3 | - HKD | 0.0% |
| 2018 Q4 | - HKD | 0.0% |
| 2018 Q1 | - HKD | 0.0% |
| 2017 Q4 | - HKD | 0.0% |
| 2017 FY | - HKD | 0.0% |
| 2017 Q3 | - HKD | 0.0% |
| 2017 Q2 | - HKD | 0.0% |
| 2017 Q1 | - HKD | 0.0% |
| 2016 FY | - HKD | 0.0% |
| 2016 Q4 | - HKD | 0.0% |
| 2016 Q3 | - HKD | 0.0% |
| 2016 Q2 | - HKD | 0.0% |
| 2016 Q1 | - HKD | 0.0% |
| 2015 Q4 | - HKD | 0.0% |
| 2015 FY | - HKD | 0.0% |
| 2015 Q3 | - HKD | 0.0% |
| 2015 Q2 | - HKD | 0.0% |
| 2015 Q1 | - HKD | 0.0% |
| 2014 Q3 | - HKD | 0.0% |
| 2014 FY | - HKD | 0.0% |
| 2014 Q1 | - HKD | 0.0% |
| 2013 Q4 | - HKD | -100.0% |
| 2013 FY | - HKD | -100.0% |
| 2013 Q1 | 97.8 Million HKD | 0.0% |
| 2013 Q2 | 104.49 Million HKD | 6.84% |
| 2013 Q3 | 104.49 Million HKD | 0.0% |
| 2012 Q1 | 51.13 Million HKD | 0.0% |
| 2012 FY | 97.8 Million HKD | 91.27% |
| 2012 Q2 | 55.12 Million HKD | 7.81% |
| 2012 Q3 | 55.12 Million HKD | 0.0% |
| 2012 Q4 | 97.8 Million HKD | 77.4% |
| 2011 Q1 | 1.54 Million HKD | 0.0% |
| 2011 Q4 | 51.13 Million HKD | -9.3% |
| 2011 FY | 51.13 Million HKD | 3209.58% |
| 2011 Q3 | 56.37 Million HKD | 0.0% |
| 2010 Q1 | - HKD | 0.0% |
| 2010 Q3 | - HKD | 0.0% |
| 2010 FY | 1.54 Million HKD | 0.0% |
| 2009 FY | - HKD | -100.0% |
| 2008 FY | 15.34 Million HKD | 0.0% |
| 2007 FY | - HKD | -100.0% |
| 2006 FY | 89.02 Million HKD | 135.24% |
| 2005 FY | 37.84 Million HKD | 0.0% |
| 2004 FY | - HKD | 0.0% |
| 2003 FY | - HKD | -100.0% |
| 2002 FY | 18.51 Million HKD | 95.98% |
| 2001 FY | 9.44 Million HKD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| CK Life Sciences Int'l., (Holdings) Inc. | 4.27 Billion HKD | 99.284% |